Target intelligence / Profile preview

Enamel hydroxyapatite crystal lattice (None; HAp is used for hydroxyapatite, but not specifically for the enamel lattice)

Target
None; HAp is used for hydroxyapatite, but not specifically for the enamel lattice
Molecular classification
Other (biomineral, not a protein, receptor, transporter, etc.), Inorganic matrix
01

Overview

Enamel hydroxyapatite crystal lattice is the highly ordered arrangement of hydroxyapatite (Ca$_{10}$(PO$_{4}$)$_{6}$(OH)$_{2}$) crystals in tooth enamel. These crystals are carbonated and contain trace elements, increasing their biological solubility but providing exceptional hardness to teeth. Hydroxyapatite crystals are organized into rods and interrod regions, encased and segregated by organic matrix proteins (enamelins). This hierarchical, nanocomposite organization—and variation in crystal orientation—accounts for enamel’s remarkable resilience under physical and chemical challenges. Demineralization occurs when acidity dissolves the hydroxyapatite lattice, leading to caries; remineralization therapies aim to restore lost crystal structure. The lattice itself is not a classical molecular target for drugs, but its modification by fluoride and remineralization is key to dental health.

Other names
Hydroxyapatite enamelEnamel mineral phaseEnamel latticeBiological hydroxyapatiteApatite crystal lattice
02

Mechanism of action

Fluoride incorporates into the lattice, forming fluorapatite, making enamel less soluble in acid Remineralization agents supply calcium and phosphate ions to restore lost crystalline mineral

03

Biological functions

Tooth hardness and protectionResistance to mechanical forces (mastication)Resistance to demineralization
04

Disease associations

Dental caries (demineralization and breakdown of crystal lattice)Tooth sensitivityEnamel defects/disorders (amelogenesis imperfecta)
05

Safety considerations

Demineralization at low pH leads to cariesNo direct safety concerns for drug targeting; main challenge is inability to regenerate enamelExcess fluoride can cause fluorosis (altered lattice)
06

Interacting drugs

Fluoride (promotes formation of fluorapatite, increases acid resistance)

3 more in the full profile.

07

Biomarkers

Degree of enamel mineralization (by density/imaging)Surface microhardnessAcid dissolution/critical pH threshold

Beyond the preview

Go deeper on Enamel hydroxyapatite crystal lattice (None; HAp is used for hydroxyapatite, but not specifically for the enamel lattice).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enamel hydroxyapatite crystal lattice (None; HAp is used for hydroxyapatite, but not specifically for the enamel lattice).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call